Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 May;73(9):1126–1131. doi: 10.1038/bjc.1996.216

Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors.

J Westerdahl 1, H Olsson 1, A Måsbäck 1, C Ingvar 1, N Jonsson 1
PMCID: PMC2074414  PMID: 8624275

Abstract

In a population-based, matched case-control study from southern Sweden of 400 patients with a first diagnosis of malignant melanoma and 640 healthy control subjects aged 15-75 years, the association between commonly prescribed drugs, alcohol, smoking and malignant melanoma was evaluated. In addition, the relation between reproductive and hormonal factors and melanoma in women was studied. It was found that certain specific types of prescribed drugs, i.e. beta-blockers, hydralazines and benzodiazepines, may increase the risk of melanoma development. However, these associations were diminished, at least for benzodiazepines, after controlling for host factors. As these findings are unconfirmed, and may be due to chance or confounding, further studies are warranted. The risk of malignant melanoma was not influenced by alcohol consumption or smoking habits. Our results do not suggest an association between oral contraceptives and melanoma. Furthermore, reproductive factors were not independent risk factors for melanoma. However, increasing number of live births seemed to be protective (P for trend = 0.01). There is a need for further research to be able to draw firm conclusions on the relation between number of live births and melanoma. The results based on histopathological re-examinations and those based on tumour registry data were essentially the same.

Full text

PDF
1126

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam S. A., Sheaves J. K., Wright N. H., Mosser G., Harris R. W., Vessey M. P. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer. 1981 Jul;44(1):45–50. doi: 10.1038/bjc.1981.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Agarwal R., Medrano E. E., Khan I. U., Nordlund J. J., Mukhtar H. Metabolism of benzo[a]pyrene by human melanocytes in culture. Carcinogenesis. 1991 Oct;12(10):1963–1966. doi: 10.1093/carcin/12.10.1963. [DOI] [PubMed] [Google Scholar]
  3. Allen J. E. Drug-induced photosensitivity. Clin Pharm. 1993 Aug;12(8):580–587. [PubMed] [Google Scholar]
  4. Bain C., Green A., Siskind V., Alexander J., Harvey P. Diet and melanoma. An exploratory case-control study. Ann Epidemiol. 1993 May;3(3):235–238. doi: 10.1016/1047-2797(93)90024-x. [DOI] [PubMed] [Google Scholar]
  5. Bain C., Hennekens C. H., Speizer F. E., Rosner B., Willett W., Belanger C. Oral contraceptive use and malignant melanoma. J Natl Cancer Inst. 1982 Apr;68(4):537–539. [PubMed] [Google Scholar]
  6. Beral V., Evans S., Shaw H., Milton G. Oral contraceptive use and malignant melanoma in Australia. Br J Cancer. 1984 Nov;50(5):681–685. doi: 10.1038/bjc.1984.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Beral V., Ramcharan S., Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer. 1977 Dec;36(6):804–809. doi: 10.1038/bjc.1977.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gallagher R. P., Elwood J. M., Hill G. B., Coldman A. J., Threlfall W. J., Spinelli J. J. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study. Br J Cancer. 1985 Dec;52(6):901–907. doi: 10.1038/bjc.1985.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Green A., Bain C. Hormonal factors and melanoma in women. Med J Aust. 1985 Apr 15;142(8):446–448. doi: 10.5694/j.1326-5377.1985.tb113446.x. [DOI] [PubMed] [Google Scholar]
  10. Green A., Bain C., McLennan R., Siskind V. Risk factors for cutaneous melanoma in Queensland. Recent Results Cancer Res. 1986;102:76–97. doi: 10.1007/978-3-642-82641-2_6. [DOI] [PubMed] [Google Scholar]
  11. Hannaford P. C., Villard-Mackintosh L., Vessey M. P., Kay C. R. Oral contraceptives and malignant melanoma. Br J Cancer. 1991 Mar;63(3):430–433. doi: 10.1038/bjc.1991.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Helmrich S. P., Rosenberg L., Kaufman D. W., Miller D. R., Schottenfeld D., Stolley P. D., Shapiro S. Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. J Natl Cancer Inst. 1984 Mar;72(3):617–620. [PubMed] [Google Scholar]
  13. Holly E. A. Melanoma and pregnancy. Recent Results Cancer Res. 1986;102:118–126. doi: 10.1007/978-3-642-82641-2_9. [DOI] [PubMed] [Google Scholar]
  14. Holly E. A., Weiss N. S., Liff J. M. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst. 1983 May;70(5):827–831. [PubMed] [Google Scholar]
  15. Holman C. D., Armstrong B. K., Heenan P. J. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer. 1984 Nov;50(5):673–680. doi: 10.1038/bjc.1984.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kirkpatrick C. S., White E., Lee J. A. Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol. 1994 May 1;139(9):869–880. doi: 10.1093/oxfordjournals.aje.a117093. [DOI] [PubMed] [Google Scholar]
  17. Larsson B. S. Interaction between chemicals and melanin. Pigment Cell Res. 1993 Jun;6(3):127–133. doi: 10.1111/j.1600-0749.1993.tb00591.x. [DOI] [PubMed] [Google Scholar]
  18. Lê M. G., Cabanes P. A., Desvignes V., Chanteau M. F., Mlika N., Avril M. F. Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women. Cancer Causes Control. 1992 May;3(3):199–205. doi: 10.1007/BF00124252. [DOI] [PubMed] [Google Scholar]
  19. Osterlind A., Tucker M. A., Stone B. J., Jensen O. M. The Danish case-control study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Int J Cancer. 1988 Dec 15;42(6):825–828. doi: 10.1002/ijc.2910420604. [DOI] [PubMed] [Google Scholar]
  20. Paffenbarger R. S., Jr, Wing A. L., Hyde R. T. Characteristics in youth predictive of adult-onset malignant lymphomas, melanomas, and leukemias: brief communication. J Natl Cancer Inst. 1978 Jan;60(1):89–92. doi: 10.1093/jnci/60.1.89. [DOI] [PubMed] [Google Scholar]
  21. Sanchez N. P., Pathak M. A., Sato S., Fitzpatrick T. B., Sanchez J. L., Mihm M. C., Jr Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol. 1981 Jun;4(6):698–710. doi: 10.1016/s0190-9622(81)70071-9. [DOI] [PubMed] [Google Scholar]
  22. Stryker W. S., Stampfer M. J., Stein E. A., Kaplan L., Louis T. A., Sober A., Willett W. C. Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol. 1990 Apr;131(4):597–611. doi: 10.1093/oxfordjournals.aje.a115544. [DOI] [PubMed] [Google Scholar]
  23. Westerdahl J., Olsson H., Måsbäck A., Ingvar C., Jonsson N., Brandt L., Jönsson P. E., Möller T. Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. Am J Epidemiol. 1994 Oct 15;140(8):691–699. doi: 10.1093/oxfordjournals.aje.a117317. [DOI] [PubMed] [Google Scholar]
  24. Westerdahl J., Olsson H., Måsbäck A., Ingvar C., Jonsson N. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res. 1995 Feb;5(1):59–65. doi: 10.1097/00008390-199502000-00007. [DOI] [PubMed] [Google Scholar]
  25. Williams R. R., Horm J. W. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J Natl Cancer Inst. 1977 Mar;58(3):525–547. doi: 10.1093/jnci/58.3.525. [DOI] [PubMed] [Google Scholar]
  26. Zanetti R., Franceschi S., Rosso S., Bidoli E., Colonna S. Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors. Int J Epidemiol. 1990 Sep;19(3):522–526. doi: 10.1093/ije/19.3.522. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES